276 related articles for article (PubMed ID: 16301022)
1. Patients with functional heartburn are more likely to report retrosternal discomfort during wireless pH monitoring.
Lee YC; Wang HP; Chiu HM; Huang SP; Tu CH; Wu MS; Lin JT
Gastrointest Endosc; 2005 Dec; 62(6):834-41. PubMed ID: 16301022
[TBL] [Abstract][Full Text] [Related]
2. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.
Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA
Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888
[TBL] [Abstract][Full Text] [Related]
3. 24 Versus 48-hour bravo pH monitoring.
Chander B; Hanley-Williams N; Deng Y; Sheth A
J Clin Gastroenterol; 2012 Mar; 46(3):197-200. PubMed ID: 21959323
[TBL] [Abstract][Full Text] [Related]
4. Oesophageal pH monitoring using the Bravo catheter-free radio capsule.
Gillies RS; Stratford JM; Booth MI; Dehn TC
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):57-63. PubMed ID: 17206078
[TBL] [Abstract][Full Text] [Related]
5. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
[TBL] [Abstract][Full Text] [Related]
6. Accuracy and tolerability of the Bravo catheter-free pH capsule in patients between the ages of 4 and 18 years.
Croffie JM; Fitzgerald JF; Molleston JP; Gupta SK; Corkins MR; Pfefferkorn MD; Lim JR; Steiner SJ; Dadzie SK
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):559-63. PubMed ID: 18030233
[TBL] [Abstract][Full Text] [Related]
7. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring.
Bansal A; Wani S; Rastogi A; Rastogi K; Goyal A; Hall S; Singh V; Higbee A; Sharma P
Am J Gastroenterol; 2009 Dec; 104(12):2918-25. PubMed ID: 19755975
[TBL] [Abstract][Full Text] [Related]
8. [Successful esophageal pH monitoring with Bravo capsule in patients with gastroesophageal reflux disease].
Valdovinos Díaz MA; Remes Troche JM; Ruiz Aguilar JC; Schmulson MJ; Valdovinos-Andraca F
Rev Gastroenterol Mex; 2004; 69(2):62-8. PubMed ID: 15757153
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic removal of the wireless pH monitoring capsule in patients with severe discomfort.
Prakash C; Jonnalagadda S; Azar R; Clouse RE
Gastrointest Endosc; 2006 Nov; 64(5):828-32. PubMed ID: 17055889
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic usefulness of the Carlsson-Dent questionnaire in gastroesophageal reflux disease (GERD)].
Gómez-Escudero O; Remes-Troche JM; Ruíz JC; Peláez-Luna M; Schmulson MJ; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2004; 69(1):16-23. PubMed ID: 15193059
[TBL] [Abstract][Full Text] [Related]
11. Comparison of distribution of intraesophageal pH during nighttime recumbency among patients with gastroesophageal reflux disease.
Hershcovici T; Jha LK; Fass R
J Clin Gastroenterol; 2012 Aug; 46(7):562-6. PubMed ID: 22476040
[TBL] [Abstract][Full Text] [Related]
12. Optimal thresholds and discriminatory power of 48-h wireless esophageal pH monitoring in the diagnosisof GERD.
Wenner J; Johansson J; Johnsson F; Oberg S
Am J Gastroenterol; 2007 Sep; 102(9):1862-9. PubMed ID: 17509034
[TBL] [Abstract][Full Text] [Related]
13. Patient acceptance and clinical impact of Bravo monitoring in patients with previous failed catheter-based studies.
Sweis R; Fox M; Anggiansah R; Anggiansah A; Basavaraju K; Canavan R; Wong T
Aliment Pharmacol Ther; 2009 Mar; 29(6):669-76. PubMed ID: 19183144
[TBL] [Abstract][Full Text] [Related]
14. Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure.
Marchese M; Spada C; Iacopini F; Familiari P; Shah SG; Tringali A; Costamagna G
Endoscopy; 2006 Aug; 38(8):813-8. PubMed ID: 17001571
[TBL] [Abstract][Full Text] [Related]
15. Direct visualization of the Bravo pH system to ensure proper deployment.
Vanderveldt H; Barkin JS
Am J Gastroenterol; 2006 Jul; 101(7):1672-3; author reply 1673-4. PubMed ID: 16863578
[No Abstract] [Full Text] [Related]
16. Hypersensitivity to acid is associated with impaired esophageal mucosal integrity in patients with gastroesophageal reflux disease with and without esophagitis.
Weijenborg PW; Smout AJ; Verseijden C; van Veen HA; Verheij J; de Jonge WJ; Bredenoord AJ
Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G323-9. PubMed ID: 24924748
[TBL] [Abstract][Full Text] [Related]
17. Features of gastroesophageal reflux disease in women.
Lin M; Gerson LB; Lascar R; Davila M; Triadafilopoulos G
Am J Gastroenterol; 2004 Aug; 99(8):1442-7. PubMed ID: 15307857
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy, diagnostic utility and tolerance of intraesophageal pH ambulatory determination with wireless pH-testing monitoring system].
Carmona-Sánchez R; Solana-Sentíes S
Rev Gastroenterol Mex; 2004; 69(2):69-75. PubMed ID: 15757154
[TBL] [Abstract][Full Text] [Related]
19. Value of heartburn for diagnosing gastroesophageal reflux disease in severely obese patients.
Ortiz V; Ponce M; Fernández A; Martínez B; Ponce JL; Garrigues V; Ponce J
Obesity (Silver Spring); 2006 Apr; 14(4):696-700. PubMed ID: 16741272
[TBL] [Abstract][Full Text] [Related]
20. Nonerosive reflux disease.
Long JD; Orlando RC
Minerva Gastroenterol Dietol; 2007 Jun; 53(2):127-41. PubMed ID: 17557041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
